SARATOGA SPRINGS, N.Y. — BBN Racing’s Kilwin rallied from well off the pace to overtake fellow closer Ragtime and capture Saturday’s 100th running of the Grade 1, $500,000 Test presented by ...
G1 Therapeutics’ approach to cancer does not kill tumors. Instead, the biotech’s drug, trilaciclib, protects bone marrow from the damaging effects of chemotherapy, reducing the duration and severity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback